The Sunshine Act — formally the Physician Payments Sunshine Act — is a U.S. law requiring medical device and drug manufacturers to report payments and transfers of value made to physicians and teaching hospitals. These disclosures populate the Open Payments database maintained by CMS.
The data it generates is a powerful commercial intelligence source: it reveals which physicians have financial relationships with which manufacturers — including competitors.
Open Payments data, created by the Sunshine Act, lets teams see the financial ties between manufacturers and physicians. For KOL identification, it surfaces the clinicians already engaged as consultants and speakers. For competitive intelligence, it reveals which physicians are paid by competitors — a signal of existing loyalty or opportunity.
Used responsibly, this transparency supports compliance and smarter engagement strategy. It’s most powerful when combined with claims and procedure data to connect financial relationships with clinical activity.
The Physician Payments Sunshine Act is a U.S. law requiring drug and device manufacturers to report payments and transfers of value to physicians and teaching hospitals. The disclosures are published in the CMS Open Payments database for public transparency.
The Sunshine Act is the law that mandates reporting; Open Payments is the CMS database where that reported data lives. In short, the Sunshine Act creates the requirement and Open Payments is the resulting public dataset.
Teams use Open Payments data to identify physicians already engaged as consultants or speakers (potential KOLs) and to see which clinicians receive payments from competitors. Combined with claims data, it links financial relationships to clinical activity for sharper strategy.
Transfers of value include consulting and speaking fees, research payments, meals, travel, gifts, and other items of value given by manufacturers to physicians. Each is reported with a "nature of payment" category describing what it was for.